Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Mucus plugging, air trapping, and bronchiectasis are important outcome measures in assessing progressive childhood cystic fibrosis lung disease.

Robinson TE, Goris ML, Moss RB, Tian L, Kan P, Yilma M, McCoy KS, Newman B, de Jong PA, Long FR, Brody AS, Behrje R, Yates DP, Cornfield DN.

Pediatr Pulmonol. 2020 Apr;55(4):929-938. doi: 10.1002/ppul.24646. Epub 2020 Jan 21.

PMID:
31962004
2.

The strong but nonspecific relationship between 18F-FDG uptake in the lower-extremity veins and venous thromboembolism.

Zhu HJ, Hess S, Rubello D, Goris ML, Alavi A.

Nucl Med Commun. 2016 Mar;37(3):322-8. doi: 10.1097/MNM.0000000000000442.

PMID:
26671850
3.

Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types.

Lam MG, Banerjee A, Goris ML, Iagaru AH, Mittra ES, Louie JD, Sze DY.

Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1192-201. doi: 10.1007/s00259-015-3048-z. Epub 2015 Apr 28.

4.

Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT.

Lam MG, Goris ML, Iagaru AH, Mittra ES, Louie JD, Sze DY.

J Nucl Med. 2013 Dec;54(12):2055-61. doi: 10.2967/jnumed.113.123257. Epub 2013 Oct 21.

5.

An evaluation of the predictive value of mid-treatment 18F-FDG-PET/CT scans in pediatric lymphomas and undefined criteria of abnormality in quantitative analysis.

Zhu HJ, Halkar R, Alavi A, Goris ML.

Hell J Nucl Med. 2013 Sep-Dec;16(3):169-74. doi: 10.1967/s002449910093. Epub 2013 Oct 2.

PMID:
24137579
6.

Safety of repeated yttrium-90 radioembolization.

Lam MG, Louie JD, Iagaru AH, Goris ML, Sze DY.

Cardiovasc Intervent Radiol. 2013 Oct;36(5):1320-8. doi: 10.1007/s00270-013-0547-9. Epub 2013 Jan 26.

PMID:
23354961
7.

Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI-743 in patients with mitochondrial disease.

Blankenberg FG, Kinsman SL, Cohen BH, Goris ML, Spicer KM, Perlman SL, Krane EJ, Kheifets V, Thoolen M, Miller G, Enns GM.

Mol Genet Metab. 2012 Dec;107(4):690-9. doi: 10.1016/j.ymgme.2012.09.023. Epub 2012 Sep 28.

PMID:
23084792
8.

Positron emission tomography of 64Cu-DOTA-Rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL.

Natarajan A, Gowrishankar G, Nielsen CH, Wang S, Iagaru A, Goris ML, Gambhir SS.

Mol Imaging Biol. 2012 Oct;14(5):608-16. doi: 10.1007/s11307-011-0537-8.

PMID:
22231277
9.

Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels.

Mittra ES, Goris ML, Iagaru AH, Kardan A, Burton L, Berganos R, Chang E, Liu S, Shen B, Chin FT, Chen X, Gambhir SS.

Radiology. 2011 Jul;260(1):182-91. doi: 10.1148/radiol.11101139. Epub 2011 Apr 18.

10.

131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphoma.

Iagaru A, Mittra ES, Ganjoo K, Knox SJ, Goris ML.

Mol Imaging Biol. 2010 Apr;12(2):198-203. doi: 10.1007/s11307-009-0245-9. Epub 2009 Jun 20.

PMID:
19543946
11.

Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization.

Louie JD, Kothary N, Kuo WT, Hwang GL, Hofmann LV, Goris ML, Iagaru AH, Sze DY.

J Vasc Interv Radiol. 2009 May;20(5):606-13. doi: 10.1016/j.jvir.2009.01.021. Epub 2009 Apr 5.

PMID:
19345589
12.

Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.

Iagaru A, Mittra E, Yaghoubi SS, Dick DW, Quon A, Goris ML, Gambhir SS.

J Nucl Med. 2009 Apr;50(4):501-5. doi: 10.2967/jnumed.108.058339. Epub 2009 Mar 16.

13.

Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune pulmonary alveolar proteinosis.

Robinson TE, Trapnell BC, Goris ML, Quittell LM, Cornfield DN.

Chest. 2009 Mar;135(3):842-848. doi: 10.1378/chest.08-1317.

PMID:
19265094
14.

Sampling density for the quantitative evaluation of air trapping.

Goris ML, Robinson TE.

Pediatr Radiol. 2009 Mar;39(3):221-5. doi: 10.1007/s00247-008-1076-6. Epub 2008 Dec 19.

PMID:
19096836
15.

(18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?

Iagaru A, Wang Y, Mari C, Quon A, Goris ML, Horning S, Gambhir SS.

Hell J Nucl Med. 2008 Sep-Dec;11(3):153-6.

PMID:
19081857
16.

90Y-ibritumomab therapy in refractory non-Hodgkin's lymphoma: observations from 111In-ibritumomab pretreatment imaging.

Iagaru A, Gambhir SS, Goris ML.

J Nucl Med. 2008 Nov;49(11):1809-12. doi: 10.2967/jnumed.108.052928. Epub 2008 Oct 16.

17.

Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on 99mTc-MDP bone scintigraphy confirmed by (18)F-18 FDG PET/CT and bone marrow biopsy.

Iagaru A, Goris ML.

Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1746. doi: 10.1007/s00259-008-0864-4. Epub 2008 Jul 22. No abstract available.

PMID:
18648808
18.

Perspectives of molecular imaging and radioimmunotherapy in lymphoma.

Iagaru A, Goris ML, Gambhir SS.

Radiol Clin North Am. 2008 Mar;46(2):243-52, viii. doi: 10.1016/j.rcl.2008.03.007. Review.

PMID:
18619379
19.

Relative lung perfusion distribution in normal lung scans: observations and clinical implications.

Cheng CP, Taur AS, Lee GS, Goris ML, Feinstein JA.

Congenit Heart Dis. 2006 Sep;1(5):210-6. doi: 10.1111/j.1747-0803.2006.00037.x.

PMID:
18377528
20.

Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia.

Tang XN, Wang Q, Koike MA, Cheng D, Goris ML, Blankenberg FG, Yenari MA.

J Nucl Med. 2007 Nov;48(11):1822-8. Epub 2007 Oct 17.

21.

A critical discussion of computer analysis in medical imaging.

Goris ML, Zhu HJ, Robinson TE.

Proc Am Thorac Soc. 2007 Aug 1;4(4):347-9. Review.

PMID:
17652499
23.

Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancer.

Street HH, Goris ML, Fisher GA, Wessels BW, Cho C, Hernandez C, Zhu HJ, Zhang Y, Nangiana JS, Shan JS, Roberts K, Knox SJ.

Cancer Biother Radiopharm. 2006 Jun;21(3):243-56.

PMID:
16918301
24.

99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody.

Blankenberg FG, Kalinyak J, Liu L, Koike M, Cheng D, Goris ML, Green A, Vanderheyden JL, Tong DC, Yenari MA.

Eur J Nucl Med Mol Imaging. 2006 May;33(5):566-74. Epub 2006 Feb 14.

PMID:
16477433
25.

Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis.

Robinson TE, Goris ML, Zhu HJ, Chen X, Bhise P, Sheikh F, Moss RB.

Chest. 2005 Oct;128(4):2327-35.

PMID:
16236891
26.

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma.

Forero A, Weiden PL, Vose JM, Knox SJ, LoBuglio AF, Hankins J, Goris ML, Picozzi VJ, Axworthy DB, Breitz HB, Sims RB, Ghalie RG, Shen S, Meredith RF.

Blood. 2004 Jul 1;104(1):227-36. Epub 2004 Mar 2.

PMID:
14996706
27.

Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin V.

Mari C, Karabiyikoglu M, Goris ML, Tait JF, Yenari MA, Blankenberg FG.

Eur J Nucl Med Mol Imaging. 2004 May;31(5):733-9. Epub 2004 Feb 21.

PMID:
14985868
28.

An automated approach to quantitative air trapping measurements in mild cystic fibrosis.

Goris ML, Zhu HJ, Blankenberg F, Chan F, Robinson TE.

Chest. 2003 May;123(5):1655-63.

PMID:
12740287
29.

Positively labeled white blood cell scan with eosinophilia and absence of infection.

Vasanawala MS, Goris ML.

Clin Nucl Med. 2003 May;28(5):389-91.

PMID:
12702935
30.

Calculation of ejection fraction in gated SPECT.

Goris ML.

J Nucl Med. 2003 Apr;44(4):657; author reply 657. No abstract available.

31.

Therapeutic lymphangiogenesis with human recombinant VEGF-C.

Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW, Quertermous T, Alitalo K, Rockson SG.

FASEB J. 2002 Dec;16(14):1985-7. Epub 2002 Oct 18.

PMID:
12397087
32.

Three-Dimensional Quantitative Analysis of Scintigraphic Tomographic Images after Elastic Transformation to a Template.

Goris ML, Maclean M, Pace WM, Yee A, Kwan A.

Surg Technol Int. 2000 Oct;IX:81-90.

PMID:
12219283
33.

In vivo imaging of acute cardiac rejection in human patients using (99m)technetium labeled annexin V.

Kown MH, Strauss HW, Blankenberg FG, Berry GJ, Stafford-Cecil S, Tait JF, Goris ML, Robbins RC.

Am J Transplant. 2001 Sep;1(3):270-7.

34.

Interhemispheric asymmetry of regional cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder.

Langleben DD, Austin G, Krikorian G, Ridlehuber HW, Goris ML, Strauss HW.

Nucl Med Commun. 2001 Dec;22(12):1333-40.

PMID:
11711904
35.

Three-dimensional quantitative analysis of scintigraphic tomographic images after elastic transformation to a template.

Goris ML, Maclean M, Pace WM, Yee A, Kwan A.

Surg Technol Int. 2000;9:81-90.

PMID:
21136392
36.

Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.

Breitz HB, Fisher DR, Goris ML, Knox S, Ratliff B, Murtha AD, Weiden PL.

Cancer Biother Radiopharm. 1999 Oct;14(5):381-95.

PMID:
10850323
37.

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.

Knox SJ, Goris ML, Tempero M, Weiden PL, Gentner L, Breitz H, Adams GP, Axworthy D, Gaffigan S, Bryan K, Fisher DR, Colcher D, Horak ID, Weiner LM.

Clin Cancer Res. 2000 Feb;6(2):406-14.

38.

[Preliminary evaluation of the effect of an attenuation correction method in myocardial perfusion SPECT].

Cortés-Blanco A, Fujii C, Goris ML.

Rev Esp Med Nucl. 1999 Dec;18(6):416-24. Spanish.

PMID:
10611567
39.

Factors affecting and computation of myocardial perfusion reference images.

Goris ML, Hotz B, Thirion JP, Similon P.

Nucl Med Commun. 1999 Jul;20(7):627-35.

PMID:
10423765
40.

Predictions for nuclear medicine in the next decade.

Goris ML, Strauss HW.

Radiology. 1998 Jul;208(1):3-5; discussion 6-7. No abstract available.

PMID:
9646785
41.

Pulmonary SPECT imaging and the stripe sign.

Pace WM, Goris ML.

J Nucl Med. 1998 Apr;39(4):721-3.

42.

Automatic registration and alignment on a template of cardiac stress and rest reoriented SPECT images.

Declerck J, Feldmar J, Goris ML, Betting F.

IEEE Trans Med Imaging. 1997 Dec;16(6):727-37.

PMID:
9533574
43.

MRI of pulmonary embolism using Gd-DTPA-polyethylene glycol polymer enhanced 3D fast gradient echo technique in a canine model.

Li KC, Pelc LR, Napel SA, Goris ML, Lin DT, Song CK, Leung AN, Rubin GD, Hollett MD, Harris DP.

Magn Reson Imaging. 1997;15(5):543-50.

PMID:
9253998
44.

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.

Knox SJ, Goris ML, Trisler K, Negrin R, Davis T, Liles TM, Grillo-López A, Chinn P, Varns C, Ning SC, Fowler S, Deb N, Becker M, Marquez C, Levy R.

Clin Cancer Res. 1996 Mar;2(3):457-70.

45.

Organ modeling in the quantitation of planar images for distribution studies.

Goris ML, Knox SA, Nielsen KR, Bouillant O.

Cancer. 1994 Feb 1;73(3 Suppl):919-22.

PMID:
8306280
46.

The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts.

Wilder RB, McGann JK, Sutherland WR, Waller EK, Minchinton AI, Goris ML, Knox SJ.

Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):119-26.

PMID:
8270432
47.

Modelling the integration of myocardial regional perfusion and function.

Goris ML, Thompson C, Malone LJ, Franken PR.

Nucl Med Commun. 1994 Jan;15(1):9-20.

PMID:
8152699
48.

Nuclear medicine: more than just medical imaging.

Goris ML.

J Nucl Med. 1993 Sep;34(9):1617. No abstract available.

49.

Correlation of tumor sensitivity to low-dose-rate irradiation with G2/M-phase block and other radiobiological parameters.

Knox SJ, Sutherland W, Goris ML.

Radiat Res. 1993 Jul;135(1):24-31. Erratum in: Radiat Res 1993 Dec;136(3):439.

PMID:
8327657
50.

Supplemental Content

Loading ...
Support Center